# COGNITION: Genomics-Guided Precision Oncology in Early High-Risk Breast Cancer

> **NCT05906407** · — · RECRUITING · sponsor: **German Cancer Research Center** · enrollment: 2000 (estimated)

## Conditions studied

- Early-Stage Breast Cancer
- Neoadjuvant Therapy

## Interventions

- **OTHER:** Genomic Profiling / Sequencing

## Key facts

- **NCT ID:** NCT05906407
- **Lead sponsor:** German Cancer Research Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2019-04-19
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2025-03-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05906407

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05906407, "COGNITION: Genomics-Guided Precision Oncology in Early High-Risk Breast Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05906407. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*